Literature DB >> 16101467

Cardiovascular consequences of weightlessness promote advances in clinical and trauma care.

William H Cooke1, Victor A Convertino.   

Abstract

Cardiovascular adaptations driven by exposure to weightlessness cause some astronauts to experience orthostatic intolerance upon return to Earth. Maladaptations of spaceflight that lead to hemodynamic instability are temporary, and therefore astronauts provide for researchers a powerful model to study cardiovascular dysfunction in terrestrial patients. Orthostatic intolerance in astronauts is linked to changes in the autonomic control of cardiovascular function, and so patients that suffer neurocardiogenic syncope may benefit from a greater understanding of the effects of spaceflight on the autonomic nervous system. In addition, appropriate autonomic compensation is fundamental to the maintenance of stable arterial pressures and brain blood flow in patients suffering traumatic bleeding injuries. The application of lower body negative pressure (LBNP), an experimental procedure used widely in aerospace physiology, induces autonomic and hemodynamic responses that are similar to actual hemorrhage and therefore may emerge as a useful experimental tool to simulate hemorrhage in humans. Observations that standing astronauts and severely injured patients are challenged to maintain venous return has contributed to the development of an inspiratory impedance threshold device that serves as a controlled "Mueller maneuver" and has the potential to reduce orthostatic intolerance in returning astronauts and slow the progression to hemorrhagic shock in bleeding patients. In this review, we focus on describing new concepts that have arisen from studies of astronauts, patients, and victims of trauma, and highlight the necessity of developing the capability of monitoring medical information continuously and remotely. Remote medical monitoring will be essential for long-duration space missions and has the potential to save lives on the battlefield and in the civilian sector.

Entities:  

Mesh:

Year:  2005        PMID: 16101467     DOI: 10.2174/1389201054553671

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  7 in total

Review 1.  Health risks of space exploration: targeted and nontargeted oxidative injury by high-charge and high-energy particles.

Authors:  Min Li; Géraldine Gonon; Manuela Buonanno; Narongchai Autsavapromporn; Sonia M de Toledo; Debkumar Pain; Edouard I Azzam
Journal:  Antioxid Redox Signal       Date:  2013-12-06       Impact factor: 8.401

Review 2.  Microgravity and the implications for wound healing.

Authors:  Ramin Mostofizadeh Farahani; Luisa A DiPietro
Journal:  Int Wound J       Date:  2008-09-19       Impact factor: 3.315

3.  Stem cell health and tissue regeneration in microgravity.

Authors:  Elizabeth Blaber; Kevin Sato; Eduardo A C Almeida
Journal:  Stem Cells Dev       Date:  2014-12       Impact factor: 3.272

Review 4.  Exercise and non-pharmacological treatment of POTS.

Authors:  Qi Fu; Benjamin D Levine
Journal:  Auton Neurosci       Date:  2018-07-04       Impact factor: 3.145

5.  Validation of a computational platform for the analysis of the physiologic mechanisms of a human experimental model of hemorrhage.

Authors:  Richard L Summers; Kevin R Ward; Tarynn Witten; Victor A Convertino; Kathy L Ryan; Thomas G Coleman; Robert L Hester
Journal:  Resuscitation       Date:  2009-10-04       Impact factor: 5.262

Review 6.  Space flight and central nervous system: Friends or enemies? Challenges and opportunities for neuroscience and neuro-oncology.

Authors:  Giovanni Marfia; Stefania Elena Navone; Laura Guarnaccia; Rolando Campanella; Marco Locatelli; Monica Miozzo; Pietro Perelli; Giulio Della Morte; Leonardo Catamo; Pietro Tondo; Carmelo Campanella; Marco Lucertini; Giuseppe Ciniglio Appiani; Angelo Landolfi; Emanuele Garzia
Journal:  J Neurosci Res       Date:  2022-06-09       Impact factor: 4.433

7.  Microgravity induces pelvic bone loss through osteoclastic activity, osteocytic osteolysis, and osteoblastic cell cycle inhibition by CDKN1a/p21.

Authors:  Elizabeth A Blaber; Natalya Dvorochkin; Chialing Lee; Joshua S Alwood; Rukhsana Yousuf; Piero Pianetta; Ruth K Globus; Brendan P Burns; Eduardo A C Almeida
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.